Viewing data from:

FLURANDRENOLIDE

ANDA

FLURANDRENOLIDE | A207133 | PADAGIS ISRAEL PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$1.16

per ml

Lowest NADAC/Unit

$1.16

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
45802092803FLURANDRENOLIDE 0.05% LOTION	$1.16	ML	Generic	—	2025-10-22

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs2 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

FARMABIOS SPAFLURANDRENOLIDE

DMF 164922003

3M COFLURANDRENOLIDE DRUG-IN-ADHESIVE R-2813

DMF 387062024

SOCIETA ITALIANA CORTICOSTEROIDI SPAInactiveFLURANDRENOLIDE

DMF 41071981

ANTIBIOTICOS SPAInactiveFLURANDRENOLIDE USP BULK FORM (NON-STERILE)

DMF 50631983

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 30, 2016	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.05%

0 patents0 exclusivities▴

LOTION;TOPICAL | Approved: Aug 30, 2016

No patent or exclusivity listings for this strength.